Showing 481-490 of 3851 results for "".
In-depth Content
https://practicaldermatology.com/topics/practice-management/in-depth-content/18306/Crisp, concise content is the need of the hour when it comes to your dermatology website. This Ekwa Marketing video outlines how you can achieve this with the help of short, bite-sized answers to long-tail questions that can then be shared on your site and social media.CSF 2017 Sneak Peek: Joel on Joel
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/csf-2017-sneak-peek-joel-on-joel/18402/Learn about the philosophy of Cosmetic Surgery Forum and get a taste for what the 2017 meeting will offer in this conversation between Joel L. Cohen, MD and CSF Founder, Joel Schlessinger, MD. Cosmetic Surgery Forum will be held November 29 thru December 2 at the Ballagio, Las Vegas.Rhatigan to Merz, MOC Dissatisfaction, Syneron-Candela Sale
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-rhatigan-to-merz-moc-dissatisfaction-syneron-candela-sale/18485/Industry veteran Bob Rhatigan is the new President and Chief Executive Officer of Merz North America. Patrick Urban is new Chief Commercial Officer. In a transaction valued at approximately $397 million, an affiliate of funds advised by Apax Partners will acquire all of the outstanding shares of SyBody Language
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/body-language/18725/Realistic expectations are the key to success for non-invasive body contouring and fat reduction, Jeanine Downie, MD tells Dermtube host Joel Cohen, MD. Combining procedures often achieve the most impressive results. Dr. Downie also shares tips for choosing and using cosmeceuticals in this exclusiveNew and Emerging Treatments in Aesthetic Dermatology
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-and-emerging-treatments-in-aesthetic-dermatology/18819/Joel Cohen, MD provides an update on innovative treatments in aesthetic dermatology that have really blossomed in the last year, such as combination non-ablative and ablative fractional and bipolar radiofrequency. He also says there are now great modalities to treat the whole patient—from the neck,Bellafill Fills a Niche; Soolantra Targets Rosacea
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-bellafill-fills-a-niche-soolantra-targets-rosacea-/18995/In this edition of DermWireTV from the editors of Practical Dermatology® magazine, a look at the approval of Bellafill (Suneva) to treat acne scars and Soolantra (Ivermectin 1%, Galderma) to treat rosacea. Plus, Benzac (Galderma) is now available OTC to treat acne, and Opdivo (Bristol-Myers Squibb)The Big Idea: Jeanine Downie, MD on Hiring Decisions
https://practicaldermatology.com/topics/practice-management/the-big-idea-jeanine-downie-md-on-hiring-decisions/19277/Dr. Downie discusses the important considerations in hiring, including how to spot the best candidates and ensure a top-notch patient experience. Featured in "What's the Big Idea"DermWireTV: Diagnosing Melanoma Using Deep-Learning Model; New Adbry Approval
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-diagnosing-melanoma-using-deep-learning-model-new-adbry-approval/26445/In this week's DermWireTV, researchers develop a novel deep-learning model designed to more accurately diagnose melanoma; LEO Pharma receives a new approval for atopic dermatitis drug Adbry; and in our PA Perspectives segment, Andrew Mastro discusses how to build an inflammatory clinic.Balancing a Busy Career: Mentorship Session With Dr. Peter Lio
https://practicaldermatology.com/youngmd-connect/on-demand-virtual-sessions/balancing-a-busy-career-mentorship-session-with-dr-peter-lio/48812/Peter A. Lio, MD, a Clinical Assistant Professor of Dermatology & Pediatrics at Northwestern University Feinberg School of Medicine, discusses how he balances his clinical practice with his academic responsibilities, thought leadership, and more in this "Ask Me Anything" mentorship session.FDA Approves Bimzelx for Hidradenitis Suppurativa
https://practicaldermatology.com/series/dermwire-tv/fda-approves-bimzelx-hidradenitis-suppurativa/29518/In this week's DermwireTV, the FDA approves a new treatment for moderate to severe hidradenitis suppurativa; the FDA agrees to review the resubmission of Dupixent for the treatment of CSU; and the president of Merz Aesthetics, North America, joins us to discuss trends in the aesthetic market.